Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.

MLA

Brunden, Kurt R., et al. “Tau-Directed Drug Discovery for Alzheimer’s Disease and Related Tauopathies: A Focus on Tau Assembly Inhibitors.” Experimental Neurology, vol. 223, no. 2, June 2010, pp. 304–10. EBSCOhost, https://doi.org/10.1016/j.expneurol.2009.08.031.

APA

Brunden, K. R., Ballatore, C., Crowe, A., Smith, A. B., 3rd, Lee, V. M.-Y., & Trojanowski, J. Q. (2010). Tau-directed drug discovery for Alzheimer’s disease and related tauopathies: a focus on tau assembly inhibitors. Experimental Neurology, 223(2), 304–310. https://doi.org/10.1016/j.expneurol.2009.08.031

Chicago

Brunden, Kurt R, Carlo Ballatore, Alex Crowe, Amos B Smith 3rd, Virginia M-Y Lee, and John Q Trojanowski. 2010. “Tau-Directed Drug Discovery for Alzheimer’s Disease and Related Tauopathies: A Focus on Tau Assembly Inhibitors.” Experimental Neurology 223 (2): 304–10. doi:10.1016/j.expneurol.2009.08.031.